IL2 and Huntington disease: Comparing the production of IL-2 between HD patients and HV individuals, we observed that, while similar amounts of IL-2 were produced between these groups at V2+3M (p = 0.15), there was a significant IL-2 decrease in HV individuals compared to HD patients at V3+3M (p = 0.0008) (Figure 1D).